APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cognitive Enhancer

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cognitive Enhancer Industry Growth and Trends Forecast to 2032

20 December 202599 pages

Choose your research edition.

Industry ResearchCognitive Enhancer Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognitive Enhancer Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Cognitive Enhancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognitive Enhancer Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognitive Enhancer Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cognitive Enhancer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cognitive Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cognitive Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cognitive Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cognitive Enhancer include Takeda, Eisai Co, Johnson & Johnson, Novartis, Pfizer, Ceretropic, Cephalon, AlternaScript and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cognitive Enhancer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cognitive Enhancer market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cognitive Enhancer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cognitive Enhancer.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cognitive Enhancer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cognitive Enhancer Market by Company

Takeda

Eisai Co

Johnson & Johnson

Novartis

Pfizer

Ceretropic

Cephalon

AlternaScript

Allergan

Cognitive Enhancer Segment by Type

Eugaroics

ADHD Medications

Nootropic Supplements

Cognitive Enhancer Segment by Application

Elderly

Child

Adult

Cognitive Enhancer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Enhancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognitive Enhancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Enhancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cognitive Enhancer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cognitive Enhancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Eugaroics Table 2. Major Company of ADHD Medications Table 3. Major Company of Nootropic Supplements Table 4. Global Cognitive Enhancer Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cognitive Enhancer Sales by Type (2021-2026) & (k units) Table 6. Global Cognitive Enhancer Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cognitive Enhancer Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cognitive Enhancer Sales Market Share in Value by Type (2021-2026) Table 9. Global Cognitive Enhancer Price by Type (2021-2026) & (US$/unit) Table 10. Global Cognitive Enhancer Sales by Type (2027-2032) & (k units) Table 11. Global Cognitive Enhancer Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cognitive Enhancer Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cognitive Enhancer Sales Market Share in Value by Type (2027-2032) Table 14. Global Cognitive Enhancer Price by Type (2027-2032) & (US$/unit) Table 15. North America Cognitive Enhancer Sales by Type (2021-2026) & (k units) Table 16. North America Cognitive Enhancer Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cognitive Enhancer Sales by Type (2021-2026) & (k units) Table 18. Europe Cognitive Enhancer Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cognitive Enhancer Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Cognitive Enhancer Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cognitive Enhancer Sales by Type (2021-2026) & (k units) Table 22. Latin America Cognitive Enhancer Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cognitive Enhancer Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Cognitive Enhancer Sales by Type (2021-2026) & (US$ Million) Table 25. Cognitive Enhancer Industry Trends Table 26. Cognitive Enhancer Industry Drivers Table 27. Cognitive Enhancer Industry Opportunities and Challenges Table 28. Cognitive Enhancer Industry Restraints Table 29. Global Cognitive Enhancer Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cognitive Enhancer Revenue Market Share by Company (2021-2026) Table 31. Global Cognitive Enhancer Sales by Company (2021-2026) & (k units) Table 32. Global Cognitive Enhancer Sales Share by Company (2021-2026) Table 33. Global Cognitive Enhancer Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Cognitive Enhancer Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cognitive Enhancer Major Company Production Sites and Headquarters Table 36. Global Cognitive Enhancer Company, Product Type & Application Table 37. Global Cognitive Enhancer Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cognitive Enhancer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cognitive Enhancer Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cognitive Enhancer Sales by Region (2021-2026) & (k units) Table 42. Global Cognitive Enhancer Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cognitive Enhancer Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cognitive Enhancer Sales Market Share in Value by Region (2021-2026) Table 45. Global Cognitive Enhancer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Cognitive Enhancer Sales by Region (2027-2032) & (k units) Table 47. Global Cognitive Enhancer Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cognitive Enhancer Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cognitive Enhancer Sales Market Share in Value by Region (2027-2032) Table 50. Global Cognitive Enhancer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Cognitive Enhancer Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cognitive Enhancer Sales by Application (2021-2026) & (k units) Table 53. Global Cognitive Enhancer Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cognitive Enhancer Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cognitive Enhancer Sales Market Share in Value by Application (2021-2026) Table 56. Global Cognitive Enhancer Price by Application (2021-2026) & (US$/unit) Table 57. Global Cognitive Enhancer Sales by Application (2027-2032) & (k units) Table 58. Global Cognitive Enhancer Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cognitive Enhancer Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cognitive Enhancer Sales Market Share in Value by Application (2027-2032) Table 61. Global Cognitive Enhancer Price by Application (2027-2032) & (US$/unit) Table 62. North America Cognitive Enhancer Sales by Application (2021-2026) & (k units) Table 63. North America Cognitive Enhancer Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cognitive Enhancer Sales by Application (2021-2026) & (k units) Table 65. Europe Cognitive Enhancer Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cognitive Enhancer Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Cognitive Enhancer Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cognitive Enhancer Sales by Application (2021-2026) & (k units) Table 69. Latin America Cognitive Enhancer Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cognitive Enhancer Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Cognitive Enhancer Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Company Information Table 73. Takeda Business Overview Table 74. Takeda Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Takeda Cognitive Enhancer Product Portfolio Table 76. Takeda Recent Development Table 77. Eisai Co Company Information Table 78. Eisai Co Business Overview Table 79. Eisai Co Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Eisai Co Cognitive Enhancer Product Portfolio Table 81. Eisai Co Recent Development Table 82. Johnson & Johnson Company Information Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Johnson & Johnson Cognitive Enhancer Product Portfolio Table 86. Johnson & Johnson Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Novartis Cognitive Enhancer Product Portfolio Table 91. Novartis Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Pfizer Cognitive Enhancer Product Portfolio Table 96. Pfizer Recent Development Table 97. Ceretropic Company Information Table 98. Ceretropic Business Overview Table 99. Ceretropic Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Ceretropic Cognitive Enhancer Product Portfolio Table 101. Ceretropic Recent Development Table 102. Cephalon Company Information Table 103. Cephalon Business Overview Table 104. Cephalon Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Cephalon Cognitive Enhancer Product Portfolio Table 106. Cephalon Recent Development Table 107. AlternaScript Company Information Table 108. AlternaScript Business Overview Table 109. AlternaScript Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. AlternaScript Cognitive Enhancer Product Portfolio Table 111. AlternaScript Recent Development Table 112. Allergan Company Information Table 113. Allergan Business Overview Table 114. Allergan Cognitive Enhancer Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Allergan Cognitive Enhancer Product Portfolio Table 116. Allergan Recent Development Table 117. North America Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. North America Cognitive Enhancer Sales by Country (2021-2026) & (k units) Table 119. North America Cognitive Enhancer Sales Market Share by Country (2021-2026) Table 120. North America Cognitive Enhancer Sales Forecast by Country (2027-2032) & (k units) Table 121. North America Cognitive Enhancer Sales Market Share Forecast by Country (2027-2032) Table 122. North America Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Cognitive Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Cognitive Enhancer Market Share by Country (2021-2026) Table 125. North America Cognitive Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Cognitive Enhancer Market Share Forecast by Country (2027-2032) Table 127. Europe Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Europe Cognitive Enhancer Sales by Country (2021-2026) & (k units) Table 129. Europe Cognitive Enhancer Sales Market Share by Country (2021-2026) Table 130. Europe Cognitive Enhancer Sales Forecast by Country (2027-2032) & (k units) Table 131. Europe Cognitive Enhancer Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Cognitive Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Cognitive Enhancer Market Share by Country (2021-2026) Table 135. Europe Cognitive Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Cognitive Enhancer Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Cognitive Enhancer Sales by Country (2021-2026) & (k units) Table 139. Asia-Pacific Cognitive Enhancer Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Cognitive Enhancer Sales Forecast by Country (2027-2032) & (k units) Table 141. Asia-Pacific Cognitive Enhancer Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Cognitive Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Cognitive Enhancer Market Share by Country (2021-2026) Table 145. Asia-Pacific Cognitive Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Cognitive Enhancer Market Share Forecast by Country (2027-2032) Table 147. Latin America Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Latin America Cognitive Enhancer Sales by Country (2021-2026) & (k units) Table 149. Latin America Cognitive Enhancer Sales Market Share by Country (2021-2026) Table 150. Latin America Cognitive Enhancer Sales Forecast by Country (2027-2032) & (k units) Table 151. Latin America Cognitive Enhancer Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Cognitive Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Cognitive Enhancer Market Share by Country (2021-2026) Table 155. Latin America Cognitive Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Cognitive Enhancer Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Cognitive Enhancer Sales by Country (2021-2026) & (k units) Table 159. Middle East and Africa Cognitive Enhancer Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Cognitive Enhancer Sales Forecast by Country (2027-2032) & (k units) Table 161. Middle East and Africa Cognitive Enhancer Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Cognitive Enhancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Cognitive Enhancer Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Cognitive Enhancer Market Share by Country (2021-2026) Table 165. Middle East and Africa Cognitive Enhancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Cognitive Enhancer Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Cognitive Enhancer Distributors List Table 170. Cognitive Enhancer Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Cognitive Enhancer Image Figure 2. Global Cognitive Enhancer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cognitive Enhancer Market Size (2021-2032) & (US$ Million) Figure 4. Global Cognitive Enhancer Sales (2021-2032) & (k units) Figure 5. Eugaroics Image Figure 6. Global Eugaroics Sales YoY Growth (2021-2032) & (k units) Figure 7. ADHD Medications Image Figure 8. Global ADHD Medications Sales YoY Growth (2021-2032) & (k units) Figure 9. Nootropic Supplements Image Figure 10. Global Nootropic Supplements Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Cognitive Enhancer Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cognitive Enhancer Market Share by Type 2025 VS 2032 Figure 13. North America Cognitive Enhancer Sales Market Share in Volume by Type in 2025 Figure 14. North America Cognitive Enhancer Sales Market Share in Value by Type in 2025 Figure 15. Europe Cognitive Enhancer Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cognitive Enhancer Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cognitive Enhancer Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cognitive Enhancer Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cognitive Enhancer Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cognitive Enhancer Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cognitive Enhancer Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cognitive Enhancer Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cognitive Enhancer Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Elderly Image Figure 26. Global Elderly Sales YoY Growth (2021-2032) & (k units) Figure 27. Child Image Figure 28. Global Child Sales YoY Growth (2021-2032) & (k units) Figure 29. Adult Image Figure 30. Global Adult Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Cognitive Enhancer Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cognitive Enhancer Market Share by Application 2025 VS 2032 Figure 33. North America Cognitive Enhancer Sales Market Share in Volume by Application in 2025 Figure 34. North America Cognitive Enhancer Sales Market Share in Value by Application in 2025 Figure 35. Europe Cognitive Enhancer Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cognitive Enhancer Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cognitive Enhancer Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cognitive Enhancer Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cognitive Enhancer Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cognitive Enhancer Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cognitive Enhancer Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cognitive Enhancer Sales Market Share in Value by Application in 2025 Figure 43. North America Cognitive Enhancer Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Cognitive Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cognitive Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cognitive Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cognitive Enhancer Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Cognitive Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cognitive Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cognitive Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cognitive Enhancer Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Cognitive Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cognitive Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cognitive Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cognitive Enhancer Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Cognitive Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cognitive Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cognitive Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cognitive Enhancer Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Cognitive Enhancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cognitive Enhancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cognitive Enhancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cognitive Enhancer Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cognitive Enhancer Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Eugaroics
  • ADHD Medications
  • Nootropic Supplements
Applications
  • Elderly
  • Child
  • Adult
Companies covered
  • Takeda
  • Eisai Co
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Ceretropic
  • Cephalon
  • AlternaScript
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cognitive Enhancer Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cognitive Enhancer Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cognitive Enhancer Market by Type
  6. 1.3.1 Eugaroics
  7. 1.3.2 ADHD Medications
  8. 1.3.3 Nootropic Supplements
  9. 1.4 Global Cognitive Enhancer Market Size by Type
  10. 1.4.1 Global Cognitive Enhancer Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cognitive Enhancer Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cognitive Enhancer Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cognitive Enhancer Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cognitive Enhancer Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cognitive Enhancer Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cognitive Enhancer Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cognitive Enhancer Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cognitive Enhancer Industry Trends
  2. 2.2 Cognitive Enhancer Industry Drivers
  3. 2.3 Cognitive Enhancer Industry Opportunities and Challenges
  4. 2.4 Cognitive Enhancer Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cognitive Enhancer Revenue (2021-2026)
  2. 3.2 Global Top Players by Cognitive Enhancer Sales (2021-2026)
  3. 3.3 Global Top Players by Cognitive Enhancer Price (2021-2026)
  4. 3.4 Global Cognitive Enhancer Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cognitive Enhancer Major Company Production Sites & Headquarters
  6. 3.6 Global Cognitive Enhancer Company, Product Type & Application
  7. 3.7 Global Cognitive Enhancer Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cognitive Enhancer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cognitive Enhancer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cognitive Enhancer Tier 1, Tier 2, and Tier 3
4 Cognitive Enhancer Regional Status and Outlook
  1. 4.1 Global Cognitive Enhancer Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cognitive Enhancer Historic Market Size by Region
  3. 4.2.1 Global Cognitive Enhancer Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cognitive Enhancer Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cognitive Enhancer Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cognitive Enhancer Forecasted Market Size by Region
  7. 4.3.1 Global Cognitive Enhancer Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cognitive Enhancer Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cognitive Enhancer Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cognitive Enhancer by Application
  1. 5.1 Cognitive Enhancer Market by Application
  2. 5.1.1 Elderly
  3. 5.1.2 Child
  4. 5.1.3 Adult
  5. 5.2 Global Cognitive Enhancer Market Size by Application
  6. 5.2.1 Global Cognitive Enhancer Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cognitive Enhancer Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cognitive Enhancer Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cognitive Enhancer Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cognitive Enhancer Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cognitive Enhancer Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cognitive Enhancer Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cognitive Enhancer Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Cognitive Enhancer Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Eisai Co
  8. 6.2.1 Eisai Co Company Information
  9. 6.2.2 Eisai Co Business Overview
  10. 6.2.3 Eisai Co Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Co Cognitive Enhancer Product Portfolio
  12. 6.2.5 Eisai Co Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Cognitive Enhancer Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Cognitive Enhancer Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Cognitive Enhancer Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Ceretropic
  32. 6.6.1 Ceretropic Company Information
  33. 6.6.2 Ceretropic Business Overview
  34. 6.6.3 Ceretropic Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ceretropic Cognitive Enhancer Product Portfolio
  36. 6.6.5 Ceretropic Recent Developments
  37. 6.7 Cephalon
  38. 6.7.1 Cephalon Company Information
  39. 6.7.2 Cephalon Business Overview
  40. 6.7.3 Cephalon Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cephalon Cognitive Enhancer Product Portfolio
  42. 6.7.5 Cephalon Recent Developments
  43. 6.8 AlternaScript
  44. 6.8.1 AlternaScript Company Information
  45. 6.8.2 AlternaScript Business Overview
  46. 6.8.3 AlternaScript Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AlternaScript Cognitive Enhancer Product Portfolio
  48. 6.8.5 AlternaScript Recent Developments
  49. 6.9 Allergan
  50. 6.9.1 Allergan Company Information
  51. 6.9.2 Allergan Business Overview
  52. 6.9.3 Allergan Cognitive Enhancer Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Allergan Cognitive Enhancer Product Portfolio
  54. 6.9.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Cognitive Enhancer Sales by Country
  2. 7.1.1 North America Cognitive Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cognitive Enhancer Sales by Country (2021-2026)
  4. 7.1.3 North America Cognitive Enhancer Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cognitive Enhancer Market Size by Country
  6. 7.2.1 North America Cognitive Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cognitive Enhancer Market Size by Country (2021-2026)
  8. 7.2.3 North America Cognitive Enhancer Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cognitive Enhancer Sales by Country
  2. 8.1.1 Europe Cognitive Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cognitive Enhancer Sales by Country (2021-2026)
  4. 8.1.3 Europe Cognitive Enhancer Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cognitive Enhancer Market Size by Country
  6. 8.2.1 Europe Cognitive Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cognitive Enhancer Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cognitive Enhancer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cognitive Enhancer Sales by Country
  2. 9.1.1 Asia-Pacific Cognitive Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cognitive Enhancer Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cognitive Enhancer Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cognitive Enhancer Market Size by Country
  6. 9.2.1 Asia-Pacific Cognitive Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cognitive Enhancer Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cognitive Enhancer Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cognitive Enhancer Sales by Country
  2. 10.1.1 South America Cognitive Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cognitive Enhancer Sales by Country (2021-2026)
  4. 10.1.3 South America Cognitive Enhancer Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cognitive Enhancer Market Size by Country
  6. 10.2.1 South America Cognitive Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cognitive Enhancer Market Size by Country (2021-2026)
  8. 10.2.3 South America Cognitive Enhancer Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cognitive Enhancer Sales by Country
  2. 11.1.1 Middle East and Africa Cognitive Enhancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cognitive Enhancer Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cognitive Enhancer Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cognitive Enhancer Market Size by Country
  6. 11.2.1 Middle East and Africa Cognitive Enhancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cognitive Enhancer Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cognitive Enhancer Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cognitive Enhancer Value Chain Analysis
  2. 12.1.1 Cognitive Enhancer Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cognitive Enhancer Production Mode & Process
  7. 12.2 Cognitive Enhancer Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cognitive Enhancer Distributors
  10. 12.2.3 Cognitive Enhancer Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst